Welcome: Guest | Site Use Options | Register | Login |

Zenopharm LLC

Zenopharm LLC

Profile last edited on: 7/25/2017
1441 Canal Street
New Orleans, LA 70112
  (504) 236-5452
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Zenopharm, LLC is organized around development of novel therapeutic products for the treatment of cancer. The company has a therapeutic portfolio that includes boron-based 4-hydroxytamoxifen and endoxifen prodrugs for treatment of breast cancer, several thiazole lead compounds that are potential anti-metastasis therapeutic regimens, and a novel anti-vasculature agent as inhibitor of tumor angiogenesis. The boron prodrugs were designed to combat de novo tamoxifen resistance and to reduce serious side effects associated with long-term tamoxifen therapy. The thiazole compounds were developed to inhibit cancer cell migration and invasion by specifically binding to fascin, an actin-bundling protein that plays a key role in tumor metastasis. The anti-vasculature agent inhibits tumor progression and metastasis by destroying existing vascular structure within the tumor and blocking new vascular formation. These drug candidates are currently under various stages of in vitro and in vivo preclinical tests.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Ind-Enabling Studies of Zb716, an Orally Bioavailable SERD

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920